Survivin, Survivin-2B, and Survivin-deltaEx3 expression in medulloblastoma:: biologic markers of tumour morphology and clinical outcome

被引:53
作者
Fangusaro, JR
Jiang, Y
Holloway, MP
Caldas, H
Singh, V
Boué, DR
Hayes, J
Altura, RA
机构
[1] Ohio State Univ, Ctr Childhood Canc Res, CCRI, Coll Med & Publ Hlth, Columbus, OH 43205 USA
[2] Ohio State Univ, Dept Pediat, Coll Med & Publ Hlth, Columbus, OH 43205 USA
[3] Ohio State Univ, Ctr Biopathol, CCRI, Columbus Childrens Hosp, Columbus, OH 43205 USA
关键词
apoptosis; medulloblastoma; Survivin; Survivin isoforms;
D O I
10.1038/sj.bjc.6602317
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Survivin is an apoptotic inhibitor that is expressed at high levels in a variety of malignancies. Survivin has four known alternative splice forms ( Survivin, Survivin-2B, Survivin-deltaEx3, and Survivin-3B), and the recent literature suggests that these splice variants have unique functions and subcellular localisation patterns. We evaluated 19 fresh-frozen paediatric medulloblastomas for the expression of three Survivin isoforms by quantitative PCR. Survivin was most highly expressed when compared with normal cerebellar tissue. We also investigated Survivin protein expression in 40 paraffin-embedded paediatric medulloblastoma tumours by immunohistochemistry. We found a statistically significant association between the percentage of Survivin-positive cells and histologic subtype, with the large-cell-anaplastic variant expressing Survivin at higher levels than the classic subtype. We also found a statistically significant relationship between the percent of Survivin-positive cells in the tumours and clinical outcome, with higher levels of Survivin correlating with a worse prognosis. In summary, our study demonstrates a role for Survivin as a marker of tumour morphology and clinical outcome in medulloblastoma. Survivin may be a promising future prognostic tool and potential biologic target in this malignancy.
引用
收藏
页码:359 / 365
页数:7
相关论文
共 46 条
[1]   Validating survivin as a cancer therapeutic target [J].
Altieri, DC .
NATURE REVIEWS CANCER, 2003, 3 (01) :46-54
[2]   Survivin, versatile modulation of cell division and apoptosis in cancer [J].
Altieri, DC .
ONCOGENE, 2003, 22 (53) :8581-8589
[3]  
Altieri DC, 1999, LAB INVEST, V79, P1327
[4]   Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade [J].
Altura, RA ;
Olshefski, RS ;
Jiang, Y ;
Boué, DR .
BRITISH JOURNAL OF CANCER, 2003, 89 (09) :1743-1749
[5]   Large cell/anaplastic medulloblastomas: A Pediatric Oncology Group study [J].
Brown, HG ;
Kepner, JL ;
Perlman, EJ ;
Friedman, HS ;
Strother, DR ;
Duffner, PK ;
Kun, LE ;
Goldthwaite, PT ;
Burger, PC .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (10) :857-865
[6]   Quantitatively determined survivin expression levels are of prognostic value in human gliomas [J].
Chakravarti, A ;
Noll, E ;
Black, PM ;
Finkelstein, DF ;
Finkelstein, DM ;
Dyson, NJ ;
Loeffler, JS .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (04) :1063-1068
[7]   Medulloblastomas with systemic metastases: Evaluation of tumor histopathology and clinical behavior in 23 patients [J].
Eberhart, CG ;
Cohen, KJ ;
Tihan, T ;
Goldthwaite, PT ;
Burger, PC .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (03) :198-203
[8]   Histopathologic grading of medulloblastomas - A pediatric oncology group study [J].
Eberhart, CG ;
Kepner, JL ;
Goldthwaite, PT ;
Kun, LE ;
Duffner, PK ;
Friedman, HS ;
Strother, DR ;
Burger, PC .
CANCER, 2002, 94 (02) :552-560
[9]   THE TREATMENT OF MEDULLOBLASTOMA - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL OF RADIATION-THERAPY WITH AND WITHOUT CCNU, VINCRISTINE, AND PREDNISONE [J].
EVANS, AE ;
JENKIN, RDT ;
SPOSTO, R ;
ORTEGA, JA ;
WILSON, CB ;
WARA, W ;
ERTEL, IJ ;
KRAMER, S ;
CHANG, CH ;
LEIKIN, SL ;
HAMMOND, GD .
JOURNAL OF NEUROSURGERY, 1990, 72 (04) :572-582
[10]  
Fortugno P, 2002, J CELL SCI, V115, P575